Trial Outcomes & Findings for Dual Focus Soft Contact Lens Wear Cessation Study (NCT NCT05779072)

NCT ID: NCT05779072

Last Updated: 2023-11-01

Results Overview

Change in spherical equivalent refractive error (SERE) relative to baseline (i.e., at end of dual focus soft contact lens wear treatment of either 3 or 6 years). Cycloplegic autorefraction was used to measure refractive error.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

83 participants

Primary outcome timeframe

1 year

Results posted on

2023-11-01

Participant Flow

Eighty-three participants were enrolled, and 76 participants completed the study. The primary reason was due to decreased vision related to astigmatism.

Unit of analysis: Eyes

Participant milestones

Participant milestones
Measure
Dual Focus for 3 Years
Group of subjects who completed dual focus soft contact lens wear treatment for 3 years. Subjects refit to Single Vision Soft Contact Lens for 1 year.
Dual Focus for 6 Years
Group of subjects who completed dual focus soft contact lens wear treatment for 6 years. Subjects refit to Single Vision Soft Contact Lens for 1 year.
Overall Study
STARTED
40 80
43 86
Overall Study
COMPLETED
39 78
37 74
Overall Study
NOT COMPLETED
1 2
6 12

Reasons for withdrawal

Reasons for withdrawal
Measure
Dual Focus for 3 Years
Group of subjects who completed dual focus soft contact lens wear treatment for 3 years. Subjects refit to Single Vision Soft Contact Lens for 1 year.
Dual Focus for 6 Years
Group of subjects who completed dual focus soft contact lens wear treatment for 6 years. Subjects refit to Single Vision Soft Contact Lens for 1 year.
Overall Study
Lost to Follow-up
0
1
Overall Study
Withdrawal by Subject
1
5

Baseline Characteristics

Dual Focus Soft Contact Lens Wear Cessation Study

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Dual Focus for 3 Years
n=40 Participants
Group of subjects who completed dual focus soft contact lens wear treatment for 3 years
Dual Focus for 6 Years
n=43 Participants
Group of subjects who completed dual focus soft contact lens wear treatment for 6 years
Total
n=83 Participants
Total of all reporting groups
Age, Continuous
16.1 years
STANDARD_DEVIATION 1.58 • n=93 Participants
16.3 years
STANDARD_DEVIATION 1.2 • n=4 Participants
16.2 years
STANDARD_DEVIATION 1.39 • n=27 Participants
Sex: Female, Male
Female
20 Participants
n=93 Participants
22 Participants
n=4 Participants
42 Participants
n=27 Participants
Sex: Female, Male
Male
20 Participants
n=93 Participants
21 Participants
n=4 Participants
41 Participants
n=27 Participants
Race/Ethnicity, Customized
Caucasian (European)
27 Participants
n=93 Participants
28 Participants
n=4 Participants
55 Participants
n=27 Participants
Race/Ethnicity, Customized
East Asian
10 Participants
n=93 Participants
13 Participants
n=4 Participants
23 Participants
n=27 Participants
Race/Ethnicity, Customized
Indian/Pakistani/SriLankan
5 Participants
n=93 Participants
3 Participants
n=4 Participants
8 Participants
n=27 Participants
Race/Ethnicity, Customized
Middle Eastern
1 Participants
n=93 Participants
0 Participants
n=4 Participants
1 Participants
n=27 Participants
Race/Ethnicity, Customized
Hispanic - Latino
0 Participants
n=93 Participants
1 Participants
n=4 Participants
1 Participants
n=27 Participants
Race/Ethnicity, Customized
Mediterranean
1 Participants
n=93 Participants
0 Participants
n=4 Participants
1 Participants
n=27 Participants
Race/Ethnicity, Customized
Black British
0 Participants
n=93 Participants
1 Participants
n=4 Participants
1 Participants
n=27 Participants

PRIMARY outcome

Timeframe: 1 year

Population: \[Not specified\]

Change in spherical equivalent refractive error (SERE) relative to baseline (i.e., at end of dual focus soft contact lens wear treatment of either 3 or 6 years). Cycloplegic autorefraction was used to measure refractive error.

Outcome measures

Outcome measures
Measure
Dual Focus for 3 Years
n=80 Eyes
Group of subjects who completed dual focus soft contact lens wear treatment for 3 years
Dual Focus for 6 Years
n=76 Eyes
Group of subjects who completed dual focus soft contact lens wear treatment for 6 years
Change in Spherical Equivalent Refractive Error (SERE)
-0.23 D
Standard Deviation 0.363
-0.21 D
Standard Deviation 0.397

PRIMARY outcome

Timeframe: 1 year

Population: \[Not Specified\]

Change in axial length (AL) relative to baseline (i.e., at end of dual focus soft contact lens wear treatment of either 3 or 6 years). Partial coherence interferometry was used to measure axial length.

Outcome measures

Outcome measures
Measure
Dual Focus for 3 Years
n=80 Eyes
Group of subjects who completed dual focus soft contact lens wear treatment for 3 years
Dual Focus for 6 Years
n=76 Eyes
Group of subjects who completed dual focus soft contact lens wear treatment for 6 years
Change in Axial Length (AL)
0.09 mm
Standard Deviation 0.090
0.10 mm
Standard Deviation 0.103

Adverse Events

Dual Focus for 3 Years

Serious events: 0 serious events
Other events: 2 other events
Deaths: 0 deaths

Dual Focus for 6 Years

Serious events: 0 serious events
Other events: 3 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Dual Focus for 3 Years
n=40 participants at risk
Group of subjects who completed dual focus soft contact lens wear treatment for 3 years
Dual Focus for 6 Years
n=43 participants at risk
Group of subjects who completed dual focus soft contact lens wear treatment for 6 years
Infections and infestations
Conjuctivitis
2.5%
1/40 • The data was collected in time frame of 1 year of study.
2.3%
1/43 • The data was collected in time frame of 1 year of study.
Product Issues
Corneal Staining
2.5%
1/40 • The data was collected in time frame of 1 year of study.
2.3%
1/43 • The data was collected in time frame of 1 year of study.
Product Issues
Discomfort
0.00%
0/40 • The data was collected in time frame of 1 year of study.
2.3%
1/43 • The data was collected in time frame of 1 year of study.

Additional Information

Paul Chamberlain

Coopervision

Phone: 9257306754

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place